9999精品视频,四虎精品成人免费观看,一级二级中文字幕在线视频,国产久视频国内精品999,亚洲综合色一区二区三区另类,久久免费大片,国产成人久久综合热,在线免费观看国产精品,91视频香蕉,无码人妻一区二区三区在线视频

  • <ul id="6ugmu"></ul>
  • 46 累計(jì)需求單數(shù)
    ¥7,240.0 累計(jì)需求金額
    0 違規(guī)次數(shù)

    52篇文獻(xiàn)

    懸賞
    已托管
    260.00
    ¥260.00
    1. 發(fā)布需求
    2. 藥智客交稿
    3. 任務(wù)主選稿中
    4. 驗(yàn)收與付款
    已完成
    交易模式:
    單人中標(biāo)
    賞金分配:
    一人獨(dú)享賞金,¥221
    具體要求:
    1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1, Cini C1, Butterfield DA2, Barone E1,3. 9.A multicenter study comparing the efficacy and tolerability of nisoldipine coat-core and amlodipine in patients with chronic stable angina Current Therapeutic Research Volume 59, Issue 7, July 1998, Pages 483-497 10.Procedure for the preparation of tetrahydro-1H-β-carboline-3-carboxylic acid esters 11.Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes 12.Characterization of different crystal forms of iboprofen, tinidazole and lorazepan Udupa, N. Drug Development and Industrial 13.Effect of Crystallinity on Absorption and Excretion Patterns of Ibuprofen, Tinidazole and Lorazepam 14.Sa1095 - (In)Appropriate Use of Proton Pump Inhibitors in Gastroesophageal Reflux Disease 15.Mo1512 - Treatment of Functional Chest Pain: Citalopram, Amitriptylin or no Treatment 16.Sa1089 - A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan (20 Mg Once Daily) Compared to Lansoprazole (30 Mg Once-Daily) in Patients with Erosive Esophagitis (Ee) 17.Mo1195 - Effect of a New Pptent Acid Inhibitor Drug, Vonoprazan on Healing Rate of Idiopathic Peptic Ulcers 18.Mo1194 - Natural History of Gastric Ulcer in a 25 Years Follow-Up: Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drugs 19.Anorexia, vomiting and weight loss in a 22-year-old woman 20.https://econtent.hogrefe.com/doi/abs/10.1024/0300-9831/a000523?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=vit 21.文獻(xiàn):Drugs Fut 2001, 26(2): 141 ISSN 0377-8282 Copyright 2001 Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.2001.026.02.610068 Vardenafil Sorbera, L.A., Martin, L., Rabasseda, X., Castaner, J. 22.Review:Solubilizing excipients in oral and injectable formulations. Pharmaceutical Research 21(2).february Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation 23.JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 196,478,1976 24.Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation
    2019-04-29 09:15
    0條新稿件,點(diǎn)擊看看
    • jxdingge

      交稿。

      附件:
      RAR Desktop.rar
      2019-04-29 10:21 IP:上海 參與編號(hào) # 評(píng)論 舉報(bào)
      數(shù)據(jù)載入中....
      發(fā)言請(qǐng)遵守"七條底線(xiàn)",還可以輸入140個(gè)字
    • 匿名

      接任務(wù)可以嗎,下載完打包給你。

      2019-04-29 10:12 IP:紹興 參與編號(hào) # 舉報(bào)
      數(shù)據(jù)載入中....
      發(fā)言請(qǐng)遵守"七條底線(xiàn)",還可以輸入140個(gè)字
    • cwkonewelcome

      對(duì)應(yīng)以上序號(hào),1~6號(hào)文獻(xiàn),可以打包下載

      附件:
      ZIP 1-6文獻(xiàn).zip
      2019-04-29 10:08 IP:西安 參與編號(hào) # 評(píng)論 舉報(bào)
      數(shù)據(jù)載入中....
      發(fā)言請(qǐng)遵守"七條底線(xiàn)",還可以輸入140個(gè)字

    當(dāng)前為付費(fèi)需求,賞金分配方式:一人獨(dú)享賞金。

    任務(wù)主在眾多備選稿件中選擇最滿(mǎn)意的稿件,支付賞金。

    托管賞金,保障各方權(quán)益:

    任務(wù)主把所發(fā)需求的懸賞金托管到藥智網(wǎng)指定賬戶(hù),以激發(fā)眾多藥智客的參與熱情,保障任務(wù)主盡快征集到滿(mǎn)意稿件;

    同時(shí),賞金托管也是為了保障參與挑戰(zhàn)的藥智客的正當(dāng)權(quán)益。

    流程說(shuō)明:

    發(fā)布需求

    點(diǎn)擊“發(fā)布需求”按鈕,按照流程引導(dǎo),將需求詳情、具體要求描述清楚,發(fā)布到藥智網(wǎng)的藥智匯平臺(tái)。

    托管賞金

    為征集到滿(mǎn)意稿件,任務(wù)主須做好“賞金預(yù)算”,并將賞金托管到藥智網(wǎng)指定賬戶(hù),打消藥智客的顧慮,激勵(lì)藥智客積極參與需求挑戰(zhàn)。

    藥智客參與

    任務(wù)主托管賞金后,所發(fā)布的需求顯示“賞金已托管”字樣。只有托管了懸賞金的需求,能夠鼓舞眾多的藥智客參與,獲取到滿(mǎn)意的稿件!

    選擇滿(mǎn)意稿件

    任務(wù)主在眾多參與者提交的稿件中,選擇符合任務(wù)主需求的稿件。再通過(guò)互動(dòng),選擇任務(wù)主最滿(mǎn)意的稿件,并確定其為中標(biāo)稿件。

    驗(yàn)收與付款

    中標(biāo)稿件提交任務(wù)主驗(yàn)收。任務(wù)主在驗(yàn)收/驗(yàn)證期內(nèi),完成驗(yàn)收/驗(yàn)證工作。對(duì)合格稿件,通知藥智網(wǎng)支付傭金。

    評(píng)價(jià)

    雙方可以針對(duì)本次交易各自的表現(xiàn)進(jìn)行評(píng)價(jià),評(píng)價(jià)結(jié)果將影響各自的信用度和能力值。

    類(lèi)似的需求

      加載數(shù)據(jù)中...

    該需求者還有這些需求

      加載數(shù)據(jù)中...

    推薦需求

      加載數(shù)據(jù)中...
    感興趣,就投稿吧!投的越早,中標(biāo)幾率就越大! 收藏
    挖掘醫(yī)藥數(shù)據(jù),分享醫(yī)藥情報(bào)
    掃一掃,關(guān)注藥智數(shù)據(jù)公眾號(hào)

    2014 藥智再發(fā)力 我們換裝了??!

    為了讓您有更好的體驗(yàn),藥智對(duì)用戶(hù)體系和產(chǎn)品進(jìn)行了全新升級(jí)!

    我要看看
    精品成人乱色一区二区| 久久精品亚洲熟女av蜜謦| 久久性爱视频| 亚洲av成人无码久久精品| 中国精品视频一区二区三区| 日韩亚洲在线一区二区| 欧美激情乱人伦| 午夜成人精品福利网站在线观看| av无码av在线a∨天堂app| 亚洲精品在线观看自拍| 色欲色香天天天综合网www| 亚洲av成人无码网站大全| 久久亚洲高清观看| 中文字幕一区二区网址| 亚洲人成网站在线播放2019| 国产成人精品一区二区三区免费| 日韩一区二区不卡av| 免费观看日本一区二区三区| 精品国偷自产在线视频九色| 综合三区后入内射国产馆| 久久久久AV成人无码网站| 国语淫秽一区二区三区四区| 国产农村妇女精品一二区| 日本欧美国产精品| 亚洲一区二区三区一区| av无码精品一区二区三区| 夫妇交换刺激做爰视频| 亚洲一区二区精品久久岳| 久久日韩精品一区二区| 狠狠色婷婷久久一区二区三区| √最新版天堂资源在线| 亚洲精品中文字幕码专区| 国产精品二区一区二区aⅴ污介绍| 久久日本三级韩国三级| 国产精品一区二区AV不卡| 久久国产精品婷婷激情| 久久99精品久久久久久秒播 | 亚洲天堂av高清在线| 精品久久久久久久久午夜福利| 国产黄页网站在线观看免费视频 | 白白色福利视频在线观看|